Tamtam Try Tamtam free
BAT logo

BAT account plan

Leading global smokeless products

At a glance

BAT is a global tobacco and nicotine group with £25,610m of 2025 revenue, 47,000+ employees and Smokeless brands Vuse, glo and Velo.

BAT (British American Tobacco p.l.c.) is a multi-category tobacco and nicotine group selling combustibles in more than 140 markets alongside Smokeless products: Vapour (Vuse), Heated Products (glo), Modern Oral (Velo) and Traditional Oral (Grizzly, Kodiak, Camel Snus). It sells to retailers, key accounts, distributors and wholesalers and increasingly direct to consumers, and reports three regions: the U.S. (Reynolds American), AME and APMEA. FY2025 revenue was £25,610m, down 1.0% reported but up 2.1% at constant rates, with profit from operations of £9,997m and diluted EPS of 349.1p. It employs 47,000+ people and ran 36 cigarette factories in 35 markets in 2025. Its strategy, "Building a Smokeless World", targets more than 50% of revenue from Smokeless products by 2035.

Business units

Strategic priorities

Building a Smokeless World
More than 50% of revenue from Smokeless products by 2035 and 50 million Smokeless consumers by 2030; Smokeless reached 19.8% of Group revenue and 35.0m consumers in H1 2026.
Horizon 2030 growth algorithm
3-5% revenue, 4-6% adjusted profit and 5-8% adjusted diluted EPS growth, with combustibles at 1-2% and New Categories at mid-teens growth and at least a 30% contribution margin by 2030.
Modern Oral as growth driver
Velo is the global Modern Oral leader; Modern Oral revenue grew 65.9% at constant rates in H1 2026 and BAT expects industry revenue in the category to almost triple by 2030.
U.S. as growth cornerstone
A £42bn revenue pool where BAT built local Velo Plus manufacturing and over 90% weighted distribution within 18 months; Velo Max and adult-focused Vuse flavours launch in H2 2026.
Productivity and Fit2Win
£2bn of productivity savings targeted for 2026-2030 plus c.£700m of annualised Fit2Win efficiencies by end-2028, after £1.2bn saved over 2023-2025.
Combustibles focus and cash generation
Concentrate on 20 key markets with 80% of industry revenue, and generate more than £50bn of free cash flow before dividends over 2024-2030.

Latest results

In the six months to 30 June 2026 revenue was £12,235m, up 1.4% reported and 2.9% at constant rates, with the U.S. up 8.5%, AME up 0.9% and APMEA down 6.3%. New Categories revenue rose 18.0% at constant rates to £1,928m and New Category contribution rose 54.7% to £269m at a 13.8% margin. Reported profit from operations fell 15.8% to £4,266m after £370m of Fit2Win costs, while adjusted profit from operations, adjusted for Canada, rose 3.5%. For FY2026 BAT guides to revenue and adjusted profit growth at the lower end of the 3-5% and 4-6% ranges, mid-teens New Category revenue growth and leverage within 2.0-2.5x by year end.

Investments and deals

Capital expenditure
Gross capital expenditure of £648m in 2025, including Modern Oral capacity, and about £750m expected in 2026.
Fit2Win programme
A 2025-2027 programme to raise commerciality and agility, with one-off costs now about £950m; £482m incurred and c.£105m of savings realised by H1 2026.
Portfolio moves
Partial monetisation of ITC (net proceeds £1,052m), sale of the 50% Brascuba (Cuba) stake in February 2026, and exits from Vapour in several APMEA markets.
Beyond Nicotine and ventures
Btomorrow Ventures has made 30+ investments with a £350m commitment, and BAT holds 48.7% of Organigram after its Sanity Group deal, with voting capped at 30%.
AI and data foundation
Around 1,000 AI agents in daily use, AI access for every employee with a computer, and Global Shared Services transitioned to Accenture in July 2025.

Challenges and risks

Illicit trade
Illicit trade is above 15% of global tobacco volume and an estimated 70% of the U.S. vapour market; in Australia illicit is around 80% of combustibles industry volume.
Regulation and excise shocks
Generational sales bans, flavour bans, excise increases in Bangladesh and a massive excise shock in Brazil from 1 August 2026, which cut BAT's industry volume assumption to -3%.
Heated Products losses
Heated Products revenue fell 11.7% at constant rates in H1 2026; BAT calls the category highly contested, with 2026 the peak investment year.
Leverage and finance costs
Borrowings of £35,063m at H1 2026 and leverage of 2.55x adjusted for Canada at end-2025, above the 2.0-2.5x target.
Combustibles volume decline
Cigarette volume fell 4.6% to 218 billion sticks in H1 2026, and U.S. consumers downtrade to deep discount, where BAT is investing behind Doral.

What leadership says

“We said 2025 would be a deployment year – and we have delivered.”

Tadeu Marroco, Chief Executive · Combined Annual and Sustainability Report 2025, February 2026

“After a period of investment and transition, returning to our algorithm for the full year is an important milestone.”

Tadeu Marroco, Chief Executive · 2026 interim results webcast, 30 July 2026

“Two years ago, it was our biggest question mark; today it is our proof point.”

Tadeu Marroco, Chief Executive · Capital Markets Day, Winston-Salem, 29 September 2026, on the U.S.

“We are on track to deliver our growth algorithm, supported by quality revenue growth, improving profitability, strong cash generation and disciplined capital allocation.”

Johan Vandermeulen, Chief Operating Officer · Capital Markets Day, 29 September 2026

Where a supplier can help

Productivity and cost programmes
The £2bn 2026-2030 productivity target and Fit2Win route-to-market modernisation create demand for automation, procurement and operations efficiency partners.
Modern Oral capacity and supply
Modern Oral growth and the capex plan of about £750m in 2026 point to needs in pouch manufacturing capacity, packaging and supply chain.
Retail execution and age verification
U.S. Vuse flavour roll-outs to 25,000 outlets per quarter with ID-scan commitments, and enforcement against illicit vapour, favour retail technology, compliance and track-and-trace suppliers.
Data and AI capabilities
BAT's next-generation data foundation built through partnerships and around 1,000 AI agents in daily use open room for data, AI and analytics vendors.
Direct-to-consumer and B2B commerce
The growing Direct-to-Consumer e-commerce channel and digital B2B platforms for retailers support e-commerce and trade marketing tools.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like BAT?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about BAT

What does BAT do?

BAT makes and sells cigarettes in more than 140 markets and Smokeless nicotine products such as Vuse vapes, glo heated products and Velo nicotine pouches.

What was BAT's revenue in 2025?

FY2025 revenue was £25,610m, down 1.0% reported and up 2.1% at constant rates; profit from operations was £9,997m.

How many employees does BAT have?

BAT employs 47,000+ people of 137 nationalities.

What is BAT's strategy?

"Building a Smokeless World": more than 50% of revenue from Smokeless products by 2035, led by Modern Oral and the U.S., under a Horizon 2030 algorithm of 3-5% revenue and 5-8% adjusted EPS growth.

Who leads BAT?

Tadeu Marroco is Chief Executive, Luc Jobin is Chair and Dragos Constantinescu became CFO from 1 September 2026; Johan Vandermeulen is Chief Operating Officer.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)